GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth
PMID: 39794935
Source: J Immunother Cancer
Publication date:
2025-07-24
Year:
2024
Abstract
NULL